{"altmetric_id":3332364,"counts":{"readers":{"mendeley":27,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:2013577"],"posts_count":1}},"citation":{"abstract":"From a safety perspective, several issues require assessment when a decision is made to prescribe a sleep medication, including next-day residual effects, the potential for abuse, tolerance, and dependence. This article aims to provide an update of the safety profile of agents commonly used in the management of insomnia, with an emphasis on newly approved hypnotics.","abstract_source":"pubmed","altmetric_jid":"4f6fa6343cf058f6100085c0","authors":["Lieberman JA"],"first_seen_on":"2015-02-04T23:18:19+00:00","issns":[],"issue":"1","journal":"The Primary Care Companion to The Journal of Clinical Psychiatry","last_mentioned_on":1191765359,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17599165","http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1894851"],"pmcid":"PMC1894851","pmid":"17599165","pubdate":"2007-06-29T23:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"Update on the Safety Considerations in the Management of Insomnia With Hypnotics: Incorporating Modified-Release Formulations Into Primary Care","type":"article","volume":"9","mendeley_url":"http:\/\/www.mendeley.com\/research\/update-safety-considerations-management-insomnia-hypnotics-incorporating-modifiedrelease-formulation"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3631265,"mean":4.9266893682253,"rank":816091,"this_scored_higher_than_pct":63,"this_scored_higher_than":2292772,"rank_type":"exact","sample_size":3631265,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":94397,"mean":8.1049863977289,"rank":24505,"this_scored_higher_than_pct":72,"this_scored_higher_than":68802,"rank_type":"exact","sample_size":94397,"percentile":72},"this_journal":{"total_number_of_other_articles":174,"mean":3.9632485549133,"rank":46,"this_scored_higher_than_pct":43,"this_scored_higher_than":76,"rank_type":"exact","sample_size":174,"percentile":43},"similar_age_this_journal_3m":{"total_number_of_other_articles":9,"mean":0.53125,"rank":1,"this_scored_higher_than_pct":88,"this_scored_higher_than":8,"rank_type":"exact","sample_size":9,"percentile":88}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":3,"Researcher":6,"Student  > Doctoral Student":1,"Student  > Postgraduate":2,"Student  > Master":4,"Other":2,"Student  > Bachelor":5,"Professor":2},"by_discipline":{"Medicine and Dentistry":16,"Psychology":1,"Agricultural and Biological Sciences":3,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":4,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"BR":2,"MX":1,"AU":2,"ES":1}}},"posts":{"wikipedia":[{"title":"Nonbenzodiazepine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=162864166#altmetric_citation_2","license":"public","citation_ids":[3332364],"posted_on":"2007-10-07T13:55:59+00:00","summary":"Nonbenzodiazepines (sometimes referred to colloquially as &quot;Z-drug&quot;) are a class of psychoactive drugs that are very benzodiazepine-like in nature.","page_url":"http:\/\/en.wikipedia.org\/?curid=2013577","wiki_lang":"en","author":{"name":"Boghog","url":"http:\/\/en.wikipedia.org\/wiki\/User:Boghog"}}]}}